38 results

• Lawsuit Claims Abbott Endangered Children By Delaying Similac, Alimentum, and EleCare Formula Recall

  July 25, 2022

  Irvin Jackson

  The lawsuit claims Abbott knew or should have known about the contamination months before the recall, but failed to warn parents and then failed to give them a refund or replacement products.

• Abbott Plant Linked to Contaminated Similac Recall Shut Down Again Due to Flooding

  June 17, 2022

  Irvin Jackson

  An Abbott production facility which only recently restarted after being connected to a contaminated Similac recall has been shut down again due to flooding.

• Whistleblower Warned of Similac Manufacturing Problems in February 2021, CNN Reports

  June 10, 2022

  Irvin Jackson

  A former Abbott employee says the company knew about manufacturing problems at the plant a year before a recall was announced following infant illnesses and deaths.

• Following Baby Formula Contamination that Resulted in Similac Recall, Operations Resume at Abott’s Michigan Facility

  June 8, 2022

  Irvin Jackson

  Operations have resumed at an Abbott production facility in Michigan, following a massive recall due to infant formula contamination.

• FDA Commissioner Testifies to Congress on Shocking Conditions At Abbott Baby Formula Plant Linked to Similac Recall

  May 27, 2022

  Russell Maas

  FDA Commissioner Robert Califf testified before a House subcommittee on Wednesday, detailing the conditions at Abbott's Sturgis, Michigan facility which led to a Similac recall and exacerbated an infant formula shortage.

• Similac Recall Consent Decree Reached Between Abbott, DOJ and FDA to Reopen Facility and Combat Formula Shortage

  May 18, 2022

  Irvin Jackson

  The Justice Department and Abbott have reached a Similac recall consent decree which could lead to the reopening of a plant whose shutdown has contributed to a national baby formula shortage.

• Abbott To Release Similac, Other Infant Formula Products on Case-by-Case Basis, as FDA Investigation of Contamination Problems Continues

  May 2, 2022

  Irvin Jackson

  The FDA will allow Abbott to release certain specialty and metabolic infant formula products on a case-by-case basis while it undergoes enhanced testing for its main line of Similac and other formula products.

• Similac Formula Recall Issued After Salmonella, Cronobacter Infections

  February 18, 2022

  Russell Maas